Constipation on a GLP-1: Why It Happens and What Actually Works

GLP-1 medications cause constipation because they deliberately slow down your digestive system, and slower digestion means stool spends more time in the colon losing water. GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — mimic a gut hormone called glucagon-like peptide-1. One of that hormone's normal jobs is to tell your stomach to empty more slowly so you feel full longer. That delayed emptying is a feature, not a bug: it is a big part of why the medication works.

But the same signal doesn't stop at the stomach. It reduces motility further down the digestive tract too. The longer stool sits in your colon, the more water your body reabsorbs from it, and the harder and drier it gets on the way out.

Then there is the second half of the problem, which almost nobody warns you about: you are simply eating and drinking much less. A person who was eating 2,200 calories a day and drops to 1,200 has roughly halved their fiber intake without changing a single food choice. Appetite suppression blunts thirst cues too, so fluid intake quietly falls at the same time. Less bulk plus less water plus slower transit is a near-perfect recipe for a hard, infrequent stool.

This is why constipation often shows up not in week one but in weeks three to six, after appetite has really dropped or after a dose increase. If you are also dealing with [sulfur burps and reflux](/blog/sulfur-burps-on-glp1-why-they-happen-and-how-to-stop), you are seeing the same slowed-transit mechanism from the other end of the system.

You are constipated if you are having fewer than three bowel movements a week, straining, passing hard or lumpy stools, or feeling like you never fully empty — and it is the change from your own normal that matters most. Doctors use the Rome IV criteria, which looks for at least two of those features over a few months, but you do not need to wait months to act.

A practical way to think about it: bowel *frequency* matters less than bowel *comfort*. Going every other day with a soft, easy stool is fine for many people. Going every day but straining for ten minutes is not.

The Bristol Stool Scale is a genuinely useful tool here. Types 1 and 2 — separate hard lumps, or a lumpy sausage — mean stool sat too long. Types 3 and 4 — a smooth sausage or a soft snake — are the target. Take a look before you flush for a week and you'll have better information than any symptom diary.

One pattern worth naming: alternating constipation and sudden loose stools. People often assume this means the medication has "fixed itself." Usually it means harder stool is backed up and looser stool is leaking around it. Treat the constipation, not the diarrhea.

Also check what else you are taking. Iron supplements, calcium, some antidepressants, and opioid pain medication all slow the bowel independently. If you started an iron supplement for [iron deficiency during perimenopause](/blog/iron-deficiency-on-glp1-during-perimenopause-what-to-know), that alone can be the tipping point rather than the GLP-1.

Fluid comes first, always. Adding fiber to a dehydrated gut is like adding flour to a dry bowl — you get a denser mass, not a softer one. Aim for roughly 2 to 2.5 liters (about 64 to 84 ounces) of fluid a day, and spread it out rather than drinking it all at dinner. Because GLP-1 medications blunt thirst signals along with hunger signals, you will likely need a visual cue: a marked bottle, a glass refilled at set times, or an alarm.

Once fluid is genuinely adequate, add fiber slowly. The target for adults is roughly 25 to 30 grams a day, and most people on a GLP-1 are getting well under half of that. Increase by about 5 grams a week, not all at once — a sudden jump causes gas, bloating, and cramping that feels worse than the original problem. Prioritize soluble fiber (oats, chia, psyllium, kiwi, beans, pears) because it holds water and softens stool, rather than only insoluble bran which mostly adds bulk. Our full breakdown of [how much fiber to take on a GLP-1 and when](/blog/fiber-on-a-glp1-how-much-which-kind-and-when) covers the specific gram targets.

Movement is the underrated third leg. Walking stimulates colonic motility directly, and even ten to fifteen minutes after meals makes a measurable difference. If your energy is low, this is one place where a gentle walk beats a hard workout — see [walking on a GLP-1](/blog/walking-on-glp1-how-much-you-actually-need) for realistic targets.

Timing also helps. The gastrocolic reflex — your colon's natural push after a meal — is strongest in the morning after breakfast. Giving yourself an unhurried ten minutes at the same time each morning trains the pattern back.

Polyethylene glycol 3350 (sold as Miralax and generics) is the option most clinicians reach for first for GLP-1-related constipation, because it works osmotically — it pulls water into the stool — rather than forcing an already-sluggish bowel to contract harder. It is not habit-forming, it can be used daily, and it is generally well tolerated long-term. Many people make the mistake of using it only as an emergency rescue once things are already impacted; used consistently for a couple of weeks it works far better.

Magnesium citrate or magnesium oxide also work osmotically and are widely used. Magnesium glycinate, the form often taken for sleep, is deliberately formulated to be gentle on the bowel and will not do much here — the form matters, which is the same point we make in our guide to [magnesium types in menopause](/blog/magnesium-for-menopause-which-type-and-does-it-help). If you have any kidney impairment, check with your clinician before regular magnesium.

Stimulant laxatives — senna, bisacodyl — make the bowel wall contract. They are effective for occasional rescue, but leaning on them nightly for months is not the plan, particularly when the underlying cause is slowed motility that you are also treating.

Stool softeners like docusate are popular but have surprisingly weak evidence behind them; most trials find them barely better than placebo.

What to avoid: bulk-forming fiber supplements taken without adequate water, and any laxative used in the setting of severe pain, vomiting, or a distended abdomen — those symptoms need evaluation, not a laxative. Slowed gastric emptying is expected on these drugs, but if symptoms feel extreme it is worth reading our piece on [whether GLP-1s cause gastroparesis](/blog/glp1-gastroparesis-stomach-paralysis-risk-explained) to understand where the line sits.

Usually not — but it is a legitimate reason to slow down your escalation schedule. Constipation tends to spike in the one to three weeks after each dose increase and then settle as your gut adapts. If it is spiking and not settling, staying at your current dose for an extra four weeks before moving up is a common and reasonable adjustment, and it does not mean the medication has failed you.

The deciding factor is function. If you are managing with fluid, fiber, and an osmotic laxative and your stools are soft every two to three days, keep going. If you are having severe discomfort, missing work, or reaching the point of impaction, that is a conversation with your prescriber about holding the dose. Our guide on [when to increase your GLP-1 dose and when to hold](/blog/glp1-dose-escalation-when-to-increase-and-when-to-hold) walks through how clinicians think about this trade-off.

One thing worth watching: severe or persistent constipation increases pressure on the whole digestive system, and GLP-1 users already carry a modestly elevated gallstone risk from rapid weight loss, which we cover in [gallstones on a GLP-1](/blog/gallstones-on-glp1-during-menopause-the-double-risk). Right-upper-belly pain after fatty meals is a different problem from constipation and deserves its own evaluation.

Finally, if you are in midlife, the picture is layered. Estrogen decline independently changes gut transit time and the gut microbiome, which we explore in [gut health and the estrobolome in menopause](/blog/gut-health-in-menopause-estrobolome-microbiome-explained). Perimenopausal women often notice their bowels changed before they ever started a GLP-1. Treating both inputs — hormonal and medication-related — usually works better than blaming one.